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To the Editor: Hand, foot, and 
mouth disease (HFMD) is an acute 
viral infectious disease in infants 
and young children. However, since 
2008, HFMD has emerged as a major 
public health problem in the People’s 
Republic of China, resulting in 
millions of infections with hundreds 
of deaths (1). Human enteroviruses 
(HEVs), including HEV71, 
echoviruses, and coxsackie viruses A 
and B (CAV and CBV), are the major 
pathogens of HFMD (2). In mainland 
China, HEV71 and CAV16 have been 
recognized as the dominant causative 
agents for HFMD.
During a recent HFMD outbreak 
in Changchun during 2010, three of 
16 throat swab samples tested positive 
for HEV but negative for HEV71 
and CAV16 by reverse transcription 
PCR. All 3 samples were then placed 
into human rhabdomyosarcoma 
cells, and typical cytopathic effects 
were observed 3–4 days later. All the 
isolates were ﬁ  nally  characterized 
as CBV5 by using serologic and 
molecular technology and designated 
as CBV5/CC10/10, CBV5/CC10/16, 
and CBV5/CC10/17, respectively. The 
complete genome of these Changchun 
isolates was determined as described 
(3) and submitted to GenBank 
(accession nos. JN580070, JN695050, 
and JN695051, respectively. The 
genome RNA of CBV5/CC10/10 
is 7,402 bp long, and the 5′- and 
3′-untranslated regions are 743 and 
101 bp, respectively. The coding 
regions of these Changchun isolates 
are highly homologous, with amino 
acid identity of 100% and only a 3-nt 
difference exists among them. The 
complete genome of 4 CBV5 strains 
were indexed previously in GenBank, 
and the nucleotide sequence identities 
of the newly isolated CBV5/CC10/10 
with the other 4 CBV5 strains were 
among 80.6%–88.1%. Results of 
homology and phylogenetic analyses 
based on the complete viral protein 
1 sequence (849 bp) showed that the 
nucleotide identity of viral protein 
1 among 17 different CBV5 strains 
was 78.9%–95.6% and the amino 
acid identity was 92.9%–98.9%. The 
neighbor-joining tree indicated that 
the new isolated CBV5 Changchun 
strains were most closely related to 
the strains isolated from mainland 
China and that they divided into a 
distinct lineage from other CBV5 
strains outside China (Figure). CBV5 
infections were reported in mainland 
China during 2002–2010 in Zhejiang, 
Shandong, and Henan Provinces 
(4). These Changchun isolates were 
highly homologous with the recent 
Henan isolate, COXB5/Henan/2010, 
with a nucleotide identity of 88.1%. 
These results indicated that CBV5 
might have been circulating in China 
for nany years and represented an 
independent evolution tendency.
Homology and BLAST analysis 
(http://blast.ncbi.nlm.nih.gov/Blast.
cgi) based on the complete genome 
sequence showed that these newly 
CBV5 isolates have 85% identity with 
some human CBV3 strains. Because 
RNA recombination is a well-known 
phenomenon for HEVs during viral 
evolution and reemergence (5–8), 
recombination analysis between 
newly isolated CBV5 and other HEVs 
was performed by using SimPlot 
software. Similarity scanning analysis 
(online Technical Appendix Figure 1, 
wwwnc.cdc.gov/EID/pdfs/11-1524-
Techapp.pdf) by using CBV5/
CC10/10 as query sequence showed 
that the 5′ half (nt 1–4481) of the 
genome had high similarity (>93%) 
to CBV5 strain COXB5/Henan/2010, 
and the 3′ half (nt 4661–7402) showed 
high similarity (>97%) to CBV3 strain 
Beijing0811. Then, bootscanning 
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analysis (online Technical Appendix 
Figure 2) showed that CBV5/CC10/10 
was most closely related to COXB5/
Henan/2010 in the 5′ half of the 
genome, and to CBV3 Beijing0811 
in the 3′ half of the genome. Both 
analyses showed that the small 
fragment within 2C domains are highly 
similar (>84%) to a CBV5 strain from 
South Korea, CBV5/2000/CSF/KOR. 
Genetic algorithms for recombination 
detection analysis also indicated that 
the putative breakpoints were located 
within the 2C domain. We found no 
recombinant evidence between CBV5 
and other HEVs during the analysis. 
Together, these accordant results 
demonstrated that recombination 
has possibly occurred within the 2C 
domain, and these Changchun isolates 
are possibly progeny of intertypic 
and intratypic recombination of CBV 
strains circulating in China (COXB5/
Henan/2010 and Beijing0811) and 
South Korea (2000/CSF/KOR).
HEVs can be divided into ≈100 
serotypes, and intertypic or intratypic 
recombination among different 
viruses occurs frequently, which is 
information necessary for disease 
control and surveillance. In China, 
dozens of HEVs, including HEV71, 
CAV, CBV, and echoviruses, have 
been isolated from HFMD patients 
and identiﬁ  ed as the pathogens causing 
HFMD (1,2,9,10). Recombination 
events among HEVs have been shown 
to play roles in HFMD outbreaks. A 
recombinant HEV71 with CAV16 was 
suggested to be responsible for the 
HFMD outbreak in Fuyang, China, 
in 2008 (9). Recombination also 
occurred among the CAV (types 2, 4, 
5, and 10) isolates during a HFMD 
outbreak in China during 2009 (10). 
However, most recombinant studies 
have focused on CAV and poliovirus. 
Recently, Oberste et al. (6) proposed 
the possible role of recombination 
within CBV strains based on 
phylogeneic analysis of individual 
genes. Our current study identiﬁ  ed and 
characterized the newly CBV5 isolates 
from HFMD patient as intratypic and 
intertypic recombinants, and further 
surveillance is warranted that focuses 
on the emerging recombinant viruses 
among HFMD causative agents and 
investigations on the pathogenic 
role and disease associations of the 
recombinant CBVs.
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Figure. Phylogenetic analysis of 
selected human coxsackievirus 
B (CBV) strains from different 
origins based on the viral 
protein 1 gene sequences. 
The neighbor-joining tree was 
generated by using MEGA4 
software (www.megasoftware.
net), and the prototype strain 
of coxsackievirus A (CAV) 16 
was used as outgroup. The 
Changchun strains isolated 
in this study are indicated by 
triangles and other Chinese 
CBV5 strains are indicated by 
squares. Scale bars indicates 
nucleotide substitutions per site.LETTERS
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To the Editor: A recently 
published study by Falkinham 
(1) showed that 17 (46%) of 37 
households were contaminated with 
nontuberculous mycobacteria (NTM) 
of the same species as those found 
in patients with lung disease and that 
7 (41%) of 17 had the same DNA 
ﬁ  ngerprint as the patient. One patient’s 
isolate from sputum matched the isolate 
found in the shower water. Therefore, 
the patient’s lung disease was likely 
acquired by inhalation of aerosols 
while showering. An isolate from 
another patient matched the isolate 
found in tap water. If the patient drank 
the contaminated water, Mycobacteria 
avium may have reached the lungs by 
aspiration because 26% of patients 
with NTM lung disease have been 
found to experience gastroesophageal 
reﬂ   ux disease (GERD) (2). Even if 
none of these scenarios was present, 
however, NTM patient contamination 
of samples is still likely. Six of the 7 
matching households had water heater 
temperatures <125°C, indicating a 
negative correlation between NTM 
growth and temperature. Most M. 
avium and M. intracellulare are killed 
in <5 seconds (3) when exposed to 
70oC; thus, all NTM species would 
likely be killed a few seconds after 
water reached the boiling point.
In a recent study, we have 
shown that Canadian-born persons 
from ethnic groups from eastern and 
Southeast Asia were less likely to be 
colonized with M.  avium complex 
than were other ethnic groups (4). We 
hypothesized that boiling water before 
consumption, a common practice in 
persons from Asia, may have partially 
protected them against pulmonary 
colonization. Another protective 
factor is the low prevalence of GERD 
in persons from Asia (<7%) (5), 
compared with 19.8% in white persons 
from Olmstead County, Minnesota, 
USA. Future studies like that of 
Falkinham are needed to determine 
routes of transmission. Factors to 
investigate in such studies include the 
ethnicity of participants and associated 
predisposing disorders, particularly 
GERD; culturing of gastric washings; 
handwashing frequency; and water 
consumption habits (whether drinking 
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